ATE502675T1 - Verbindungen, die den ampa-rezeptor verstärken, und deren anwendung in der medizin - Google Patents
Verbindungen, die den ampa-rezeptor verstärken, und deren anwendung in der medizinInfo
- Publication number
- ATE502675T1 ATE502675T1 AT07822140T AT07822140T ATE502675T1 AT E502675 T1 ATE502675 T1 AT E502675T1 AT 07822140 T AT07822140 T AT 07822140T AT 07822140 T AT07822140 T AT 07822140T AT E502675 T1 ATE502675 T1 AT E502675T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- strengthen
- medicine
- application
- ampa receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0621967A GB0621967D0 (en) | 2006-11-03 | 2006-11-03 | Compounds |
GB0717262A GB0717262D0 (en) | 2007-09-05 | 2007-09-05 | Compounds |
PCT/EP2007/061794 WO2008053031A1 (en) | 2006-11-03 | 2007-11-01 | Compounds which potentiate ampa receptor and uses thereof in medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE502675T1 true ATE502675T1 (de) | 2011-04-15 |
Family
ID=39099804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07822140T ATE502675T1 (de) | 2006-11-03 | 2007-11-01 | Verbindungen, die den ampa-rezeptor verstärken, und deren anwendung in der medizin |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100137276A1 (de) |
EP (1) | EP2086643B1 (de) |
JP (1) | JP2010508328A (de) |
AT (1) | ATE502675T1 (de) |
DE (1) | DE602007013450D1 (de) |
WO (1) | WO2008053031A1 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0711089D0 (en) * | 2007-06-08 | 2007-07-18 | Glaxo Group Ltd | Compounds |
GB0711088D0 (en) * | 2007-06-08 | 2007-07-18 | Glaxo Group Ltd | Compounds |
US9493484B2 (en) | 2012-02-08 | 2016-11-15 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
BR112017023038A2 (pt) | 2015-04-29 | 2018-07-03 | Janssen Pharmaceutica Nv | imidazopirazinas e pirazolopirimidinas e seu uso como moduladores do receptor ampa |
MA41988B1 (fr) | 2015-04-29 | 2021-03-31 | Janssen Pharmaceutica Nv | Azabenzimidazoles et leur utilisation comme modulateurs du recepteur ampa |
US10604484B2 (en) | 2015-04-29 | 2020-03-31 | Janssen Pharmaceutica Nv | Indolone compounds and their use as AMPA receptor modulators |
MX2017013877A (es) | 2015-04-29 | 2018-08-15 | Janssen Pharmaceutica Nv | Compuestos de benzimidazolona y benzotiazolona y su uso como moduladores del receptor ampa. |
GB201702221D0 (en) | 2017-02-10 | 2017-03-29 | Univ Of Sussex | Compounds |
GB201803340D0 (en) | 2018-03-01 | 2018-04-18 | Univ Of Sussex | Compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2159479B1 (es) | 1999-10-25 | 2002-05-01 | Menarini Lab | Nuevos indazoles como inhibidores de la ciclooxigenasa-ii |
NZ552979A (en) | 2004-08-09 | 2010-02-26 | Glaxo Group Ltd | Indane and tetralin derivatives which potentiate glutamate receptor and uses thereof in medicine |
-
2007
- 2007-11-01 AT AT07822140T patent/ATE502675T1/de not_active IP Right Cessation
- 2007-11-01 JP JP2009535078A patent/JP2010508328A/ja not_active Withdrawn
- 2007-11-01 US US12/447,294 patent/US20100137276A1/en not_active Abandoned
- 2007-11-01 DE DE602007013450T patent/DE602007013450D1/de active Active
- 2007-11-01 WO PCT/EP2007/061794 patent/WO2008053031A1/en active Application Filing
- 2007-11-01 EP EP07822140A patent/EP2086643B1/de active Active
Also Published As
Publication number | Publication date |
---|---|
JP2010508328A (ja) | 2010-03-18 |
US20100137276A1 (en) | 2010-06-03 |
DE602007013450D1 (de) | 2011-05-05 |
EP2086643A1 (de) | 2009-08-12 |
EP2086643B1 (de) | 2011-03-23 |
WO2008053031A1 (en) | 2008-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE502675T1 (de) | Verbindungen, die den ampa-rezeptor verstärken, und deren anwendung in der medizin | |
EA200802007A1 (ru) | Соединения, потенцирующие рецептор амра, и применение указанных соединений в медицине | |
CY1119176T1 (el) | 5-υποκατεστημενα παραγωγα κιναζολινονης ως αντικαρκινικοι παραγοντες | |
MY145647A (en) | (4-hydroxy-2-oxo-3h-benzothiazol-7-yl)ethylamine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy (for example in the treatment of respiratory disease states) | |
ATE556074T1 (de) | Neue imidazoä1,5-aüpyridinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten | |
GB0612423D0 (en) | Therapeutic agents | |
SE0402735D0 (sv) | Novel compounds | |
NZ595738A (en) | Benzimidazole-piperidine-cyclohexane derivatives which have activity at M1 receptor and their uses in medicine | |
NO20090321L (no) | Anvendelse av substituerte 2-aminotyetraliner for produksjon av et medikament for forhindringen, lettingen og/eller behandlingen av diverse typer smerte | |
UY29384A1 (es) | Derivados del ácido2-3s,4r)-4-(((3,4-dicloro-5-metil-1h-pirrol-2-il) carbonil)amino)-1,3-tiazol-5-carboxílico y sus sales, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciónes. | |
DE602005017895D1 (de) | Pyrazolamid-derivate, diese verbindungen enthaltende zusammensetzungen und anwendungsverfahren | |
NZ612000A (en) | Bicyclo[3.2.1]octyl amide derivatives and uses of same | |
EA200701324A1 (ru) | Соединения пиридина для лечения заболеваний, опосредованных действием простагландина | |
ATE360631T1 (de) | Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors | |
ATE430744T1 (de) | Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren | |
TW200736189A (en) | Indene derivatives, their preparation and use as medicaments | |
UY30310A1 (es) | Derivados 2-azetidinona, sales, solvatos, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones | |
CY1112391T1 (el) | Υποκατεστημενες ν-φαινυλ-διπυρρολιδινη ουριες και θεραπευτικες χρησεις αυτων | |
MX2010009022A (es) | Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso. | |
MX2009013501A (es) | Compuestos piperidinicos y sus usos. | |
MX2007007027A (es) | Derivados piperazinilpiridina como agentes anti-obesidad. | |
BR112023025599A2 (pt) | Ativadores de dimetoxifenilalquilamina de receptores de serotonina. | |
UY29999A1 (es) | "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones" | |
ATE450262T1 (de) | Harnstoff-derivate als calcium-rezeptor- modulatoren | |
NO20091832L (no) | Indoler som virker via reseptorantagonister |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |